Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001493152-24-040544
Filing Date
2024-10-09
Accepted
2024-10-09 09:58:52
Documents
1
Period of Report
2024-10-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 5115
  Complete submission text file 0001493152-24-040544.txt   6715
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Issuer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1200 ROUTE 22 EAST SUITE 2000 BRIDGEWATER NJ 08807
Business Address
Appajosyula Sireesh (Reporting) CIK: 0001901565 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41210 | Film No.: 241361698